HomeInsightsStock Comparison

Gujarat Themis Biosyn Ltd vs Themis Medicare Ltd Stock Comparison

Gujarat Themis Biosyn Ltd vs Themis Medicare Ltd Stock Comparison

Last Updated on: May 29, 2025

Key Highlights

  • The Latest Trading Price of Gujarat Themis Biosyn Ltd is ₹ 310.2 as of 29 May 12:18.
  • The P/E Ratio of Gujarat Themis Biosyn Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Themis Medicare Ltd changed from 8.9 on March 2020 to 46.3 on March 2024 . This represents a CAGR of 39.07% over 5 years.
  • The Market Cap of Gujarat Themis Biosyn Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Themis Medicare Ltd changed from ₹ 220.51 crore on March 2020 to ₹ 2015 crore on March 2024 . This represents a CAGR of 55.67% over 5 years.
  • The revenue of Gujarat Themis Biosyn Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Themis Medicare Ltd for the Mar '25 is ₹ 73.25 crore as compare to the Dec '24 revenue of ₹ 94.83 crore. This represent the decline of -22.76%.
  • The ebitda of Gujarat Themis Biosyn Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Themis Medicare Ltd for the Mar '25 is ₹ -6.14 crore as compare to the Dec '24 ebitda of ₹ 6.99 crore. This represent the decline of -187%.
  • The net profit of Gujarat Themis Biosyn Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Themis Medicare Ltd changed from ₹ 18.19 crore to ₹ -9.66 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Gujarat Themis Biosyn Ltd changed from 10.12 % on March 2020 to 12.27 % on March 2024 . This represents a CAGR of 3.93% over 5 yearsThe Dividend Payout of Themis Medicare Ltd changed from 10.11 % on March 2020 to 18.59 % on March 2024 . This represents a CAGR of 12.96% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Gujarat Themis Biosyn Ltd

  • Promoted by Kantilal Shah, Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985.
  • It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007. Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990.

About Themis Medicare Ltd

  • Themis Medicare Limited was formerly incorporated as 'Themis Chemicals Limited' in 1969.
  • The Company was originally promoted by Chemosyn and Medimpex but was taken over by a Group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics, which was merged with Artemis Pharmaceuticals in April, 1993.
  • Thereafter, the name of the Company was changed to Themis Medicare Limited in 2001.
  • The Group is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity. In Mar.'95, the company came out with a public issue equity shares (premium : Rs 110) to finance the expansion-cum-modernisation of its synthetic bulk drug plant at Vapi, the setting up of a formulation unit at Lilora, Baroda as backward integration and to augment long-term working capital.

Gujarat Themis Biosyn Ltd News Hub

News

Board of Gujarat Themis Biosyn recommends final dividend

Gujarat Themis Biosyn announced that the Board of Directors of the Company at its meeting ...

Read more

21 May 2025 11:36

News

Gujarat Themis Biosyn to announce Quarterly Result

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 20 M...

Read more

16 May 2025 15:57

News

Gujarat Themis Biosyn to convene board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 14 F...

Read more

11 Feb 2025 10:53

News

Board approved merger of Gujarat Themis Biosyn with Themis Medicare

The Board of Directors of Gujarat Themis Biosyn (GTBL) and Themis Medicare (TML) have appr...

Read more

19 Nov 2024 09:10

News

Gujarat Themis Biosyn schedules board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 25 O...

Read more

19 Oct 2024 09:25

News

Gujarat Themis' Q1 PAT falls over 25% YoY to Rs 13 crore

This decline was primarily driven by a 21.7% YoY drop in net sales to Rs 38.83 crore. Tota...

Read more

27 Jul 2024 09:25

Themis Medicare Ltd News Hub

News

Board of Themis Medicare recommends final dividend

Themis Medicare announced that the Board of Directors of the Company at its meeting held o...

Read more

21 May 2025 11:37

News

Themis Medicare to declare Quarterly Results

Themis Medicare will hold a meeting of the Board of Directors of the Company on 20 May 202...

Read more

16 May 2025 16:53

News

Themis Medicare to discuss results

Themis Medicare will hold a meeting of the Board of Directors of the Company on 14 Februar...

Read more

11 Feb 2025 10:53

News

Themis Medicare to discuss results

Themis Medicare will hold a meeting of the Board of Directors of the Company on 25 October...

Read more

19 Oct 2024 10:22

News

Themis Medicare to hold board meeting

Themis Medicare will hold a meeting of the Board of Directors of the Company on 26 July 20...

Read more

17 Jul 2024 09:49

News

Board of Themis Medicare recommends final dividend

Themis Medicare announced that the Board of Directors of the Company at its meeting held o...

Read more

15 May 2024 10:44

SWOT Analysis Of Gujarat Themis Biosyn Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Themis Medicare Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Gujarat Themis Biosyn Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Themis Medicare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Gujarat Themis Biosyn Ltd and Themis Medicare Ltd

Which company has a larger market capitalization, Gujarat Themis Biosyn Ltd or Themis Medicare Ltd?

Market cap of Gujarat Themis Biosyn Ltd is 3,336 Cr while Market cap of Themis Medicare Ltd is 1,279 Cr

What are the key factors driving the stock performance of Gujarat Themis Biosyn Ltd and Themis Medicare Ltd?

The stock performance of Gujarat Themis Biosyn Ltd and Themis Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gujarat Themis Biosyn Ltd and Themis Medicare Ltd?

As of May 29, 2025, the Gujarat Themis Biosyn Ltd stock price is INR ₹306.2. On the other hand, Themis Medicare Ltd stock price is INR ₹139.0.

How do dividend payouts of Gujarat Themis Biosyn Ltd and Themis Medicare Ltd compare?

To compare the dividend payouts of Gujarat Themis Biosyn Ltd and Themis Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions